These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 6869392

  • 1. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ, Fishman DA, Kochis TR.
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [Abstract] [Full Text] [Related]

  • 2. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE.
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [Abstract] [Full Text] [Related]

  • 3. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE, Cacace L, Anderson RJ, Ackerman LA.
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [Abstract] [Full Text] [Related]

  • 4. Purchasing premixed products.
    Geberbauer CW.
    J Healthc Mater Manage; 1988 Mar; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [Abstract] [Full Text] [Related]

  • 5. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers.
    Allinson RR, Stach PE, Sherrin TP, Latiolais CJ.
    Am J Hosp Pharm; 1979 Apr; 36(4):513-7. PubMed ID: 433938
    [Abstract] [Full Text] [Related]

  • 6. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [Abstract] [Full Text] [Related]

  • 7. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [Abstract] [Full Text] [Related]

  • 8. Pharmacy-nursing communications in an intravenous admixture program.
    Muraida RM.
    Am J Hosp Pharm; 1975 Sep; 32(9):889-91. PubMed ID: 1190243
    [Abstract] [Full Text] [Related]

  • 9. Strategies for reducing i.v. drug waste and coping with increased workload.
    Hoolihan RJ, Erickson BA.
    Hosp Pharm; 1987 Sep; 22(9):871-6. PubMed ID: 10312222
    [Abstract] [Full Text] [Related]

  • 10. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ, Maher M.
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [Abstract] [Full Text] [Related]

  • 11. Decision analysis applied to the purchase of frozen premixed intravenous admixtures.
    Witte KW, Eck TA, Vogel DP.
    Am J Hosp Pharm; 1985 Apr; 42(4):835-9. PubMed ID: 4014235
    [Abstract] [Full Text] [Related]

  • 12. Cost analysis of using premixed frozen versus hospital-reconstituted cefazolin sodium injection.
    Havlovic DA, Ivey MF, Grotzinger RP.
    Am J Hosp Pharm; 1987 Apr; 44(4):783-7. PubMed ID: 3578311
    [Abstract] [Full Text] [Related]

  • 13. Antineoplastic admixture service in a tertiary-care hospital.
    Friedman TS, Triboletti M, Sandusky RM, Katz S.
    Am J Hosp Pharm; 1984 Oct; 41(10):2037-44. PubMed ID: 6496492
    [Abstract] [Full Text] [Related]

  • 14. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM, Daniels CE, Somani SM.
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [Abstract] [Full Text] [Related]

  • 15. Reference aids for developing policies and procedures for intravenous admixture services.
    Brown TR, Northern RE.
    Am J Hosp Pharm; 1979 Apr; 36(4):517-20. PubMed ID: 373432
    [Abstract] [Full Text] [Related]

  • 16. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG, Avis KE.
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [Abstract] [Full Text] [Related]

  • 17. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [Abstract] [Full Text] [Related]

  • 18. Recycled unused piggyback admixtures through the use of tamper-proof safety caps.
    Jennings RH, Schad RF, Kaurich J.
    Hosp Pharm; 1982 Dec; 17(12):643-5, 652. PubMed ID: 10257924
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ, Owen H, Popovich J, Pancorbo S.
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [Abstract] [Full Text] [Related]

  • 20. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML, Hamata L.
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.